Haleon PLC Sponsored ADR (NYSE:HLN) Receives Consensus Rating of “Moderate Buy” from Brokerages

Haleon PLC Sponsored ADR (NYSE:HLN) has earned a consensus recommendation of “Moderate Buy” from the eight research firms that are presently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, two have given a hold recommendation, four have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year price objective among analysts that have covered the stock in the last year is $12.3250.

Several analysts recently weighed in on the stock. Morgan Stanley reissued an “overweight” rating on shares of Haleon in a research note on Monday, December 15th. Jefferies Financial Group reaffirmed a “buy” rating on shares of Haleon in a research report on Tuesday, January 20th. HSBC upgraded Haleon from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, January 21st. Weiss Ratings reissued a “hold (c)” rating on shares of Haleon in a research note on Thursday, January 22nd. Finally, Deutsche Bank Aktiengesellschaft downgraded Haleon from a “hold” rating to a “sell” rating in a research report on Monday, January 12th.

Institutional Investors Weigh In On Haleon

Large investors have recently modified their holdings of the company. Parkside Financial Bank & Trust raised its holdings in shares of Haleon by 101.3% during the fourth quarter. Parkside Financial Bank & Trust now owns 2,847 shares of the company’s stock valued at $29,000 after purchasing an additional 1,433 shares during the period. SOA Wealth Advisors LLC. boosted its position in shares of Haleon by 60.5% during the 3rd quarter. SOA Wealth Advisors LLC. now owns 3,105 shares of the company’s stock worth $28,000 after purchasing an additional 1,170 shares in the last quarter. Citizens National Bank Trust Department grew its stake in shares of Haleon by 167.4% in the 3rd quarter. Citizens National Bank Trust Department now owns 3,276 shares of the company’s stock valued at $29,000 after buying an additional 2,051 shares during the period. Atlantic Union Bankshares Corp grew its stake in shares of Haleon by 293.7% in the 3rd quarter. Atlantic Union Bankshares Corp now owns 3,697 shares of the company’s stock valued at $33,000 after buying an additional 2,758 shares during the period. Finally, Stance Capital LLC bought a new stake in Haleon in the 3rd quarter valued at about $34,000. 6.67% of the stock is currently owned by institutional investors and hedge funds.

Haleon Trading Down 1.7%

HLN opened at $10.00 on Thursday. The company has a debt-to-equity ratio of 0.47, a current ratio of 0.92 and a quick ratio of 0.71. Haleon has a fifty-two week low of $8.71 and a fifty-two week high of $11.42. The company’s 50 day moving average price is $10.50 and its two-hundred day moving average price is $9.85. The firm has a market capitalization of $44.51 billion, a price-to-earnings ratio of 25.63 and a beta of 0.18.

Haleon Dividend Announcement

The company also recently declared a dividend, which will be paid on Thursday, May 14th. Shareholders of record on Friday, April 10th will be issued a dividend of $0.1307 per share. The ex-dividend date is Friday, April 10th. This represents a yield of 251.0%. Haleon’s dividend payout ratio (DPR) is presently 28.21%.

About Haleon

Haleon plc (NYSE:HLN) is a global consumer healthcare company formed through the separation of a large pharmaceutical group’s consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over‑the‑counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self‑care and symptom relief.

The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.